US Stock MarketDetailed Quotes
NERV Minerva Neurosciences
- 2.3000
- +0.0784+3.53%
Close Jan 2 16:00 ET
- 2.3000
- 0.00000.00%
Post 20:01 ET
16.08MMarket Cap-5.11P/E (TTM)
2.3000High2.2100Low5.74KVolume2.2200Open2.2216Pre Close12.95KTurnover0.11%Turnover RatioLossP/E (Static)6.99MShares13.490052wk High-0.74P/B12.51MFloat Cap2.060052wk Low--Dividend TTM5.44MShs Float126.7200Historical High--Div YieldTTM4.05%Amplitude1.2600Historical Low2.2540Avg Price1Lot Size
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Minerva Neurosciences Stock Forum
$Infobird Software (IFBD.US)$ $Ascent Solar Technologies (ASTI.US)$ $Rail Vision (RVSN.US)$ $J-Long Group (JL.US)$ $Minerva Neurosciences (NERV.US)$
📊⚡️📊
Roluperidone NDA receives CRL from FDA 🙁
⚠️ FDA cited clinical deficiencies:
▪️ Insufficient substantial evidence of effectiveness
▪️ lacks data on concomitant antipsychotic admin.
▪️ lacks data to establish change in negative symptoms of schizophrenia
▪️ inadequate number of subjects exposed at proposed dose
ℹ️Add'l info on Roluperidone…
⇒ for negative symptoms of schizophrenia
⇒ NDA
⇒ PDUFA: 02/26/24
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...
No comment yet